Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors
- 1 July 2002
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 448 (2-3) , 185-191
- https://doi.org/10.1016/s0014-2999(02)01944-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor bindingPsychopharmacology, 2000
- 18‐Methoxycoronaridine (18‐MC) and Ibogaine: Comparison of Antiaddictive Efficacy, Toxicity, and Mechanisms of ActionAnnals of the New York Academy of Sciences, 2000
- 18-MC reduces methamphetamine and nicotine self-administration in ratsNeuroReport, 2000
- Development of Novel Medications for Drug Addiction: The Legacy of an African ShrubAnnals of the New York Academy of Sciences, 2000
- Opioid analgesics as noncompetitive N-methyl-d-aspartate (NMDA) antagonistsBiochemical Pharmacology, 1998
- 18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in ratsBrain Research, 1996
- Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental areaBrain Research, 1994
- The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotinePsychopharmacology, 1992
- Effects and aftereffects of ibogaine on morphine self-administration in ratsEuropean Journal of Pharmacology, 1991
- Nicotine maintains robust self-administration in rats on a limited-access schedulePsychopharmacology, 1989